Abstract:Dietary intake of fish rich in n-3 highly unsaturated fatty acids (HUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has been proposed to decrease cancer risk. In contrast to results from laboratory studies, however, protective effects for breast cancer have proved equivocal in epidemiological studies. In the present case-control study, we examined associations between breast cancer risk and fatty acid compositions in erythrocyte membranes as biomarkers for those intakes. Dietary info… Show more
“…Our results are consistent with studies that find lower longchain omega-3 fatty acids and omega-3:6 ratios in RBCs (20,21) and adipose tissue (40,41) from women with breast cancer compared with controls. Omega-3 fatty acids are especially prone to oxidation (42), and it is possible that the lack of correlation between omega-3 fatty acids in blood and tissue and breast cancer risk in nested, case-control studies (22)(23)(24)(25)(26)(27)(28) is due to the complications of analyzing the fatty acid composition in samples stored for periods ranging from 4 to 25 years (23,25).…”
Section: Discussionsupporting
confidence: 93%
“…Case-control studies generally find an inverse association between dietary intake and/or red blood cell (RBC) fatty acid content of EPA and DHA and breast cancer risk (19)(20)(21). Prospective studies also have generally shown an inverse association between consumption of omega-3 fatty acids from fish and/or fish oil supplements and breast cancer incidence (18).…”
The ratio of omega-3 to omega-6 fatty acids, especially the longchain eicosapentaenoic acid (EPA) þ docosahexaenoic acid (DHA) to arachidonic acid (AA) ratio, is inversely associated with breast cancer risk. We measured the association between cytologic atypia, a biomarker for short-term risk of breast cancer development, and omega-3 and omega-6 fatty acid intake and levels in blood and breast tissue. Blood and benign breast tissue, sampled by random periareolar fine-needle aspiration (RPFNA), was obtained from 70 women at elevated risk for breast cancer. Self-reported dietary intake was assessed by the NCI's Food Frequency Questionnaire. The fatty acid composition of five lipid compartments, red blood cell, plasma and breast phospholipids, and plasma and breast triaclyglycerides (TAG), was analyzed by gas chromatography as weight percent. Median daily intakes of EPAþDHA and total omega-3 fatty acids were 80 mg and 1.1 g, respectively. The median total omega-3:6 intake ratio was 1:10. Compared with women without atypia, those with cytologic atypia had lower total omega-3 fatty acids in red blood cell and plasma phospholipids and lower omega-3:6 ratios in plasma TAGs and breast TAGs (P < 0.05). The EPAþDHA:AA ratio in plasma TAGs was also lower among women with atypia. This is the first report of associations between tissue levels of omega-3 and omega-6 fatty acids and a reversible tissue biomarker of breast cancer risk. RPFNA cytomorphology could serve as a surrogate endpoint for breast cancer prevention trials of omega-3 fatty acid supplementation. Cancer Prev Res; 8(5); 359-64. Ó2015 AACR.
“…Our results are consistent with studies that find lower longchain omega-3 fatty acids and omega-3:6 ratios in RBCs (20,21) and adipose tissue (40,41) from women with breast cancer compared with controls. Omega-3 fatty acids are especially prone to oxidation (42), and it is possible that the lack of correlation between omega-3 fatty acids in blood and tissue and breast cancer risk in nested, case-control studies (22)(23)(24)(25)(26)(27)(28) is due to the complications of analyzing the fatty acid composition in samples stored for periods ranging from 4 to 25 years (23,25).…”
Section: Discussionsupporting
confidence: 93%
“…Case-control studies generally find an inverse association between dietary intake and/or red blood cell (RBC) fatty acid content of EPA and DHA and breast cancer risk (19)(20)(21). Prospective studies also have generally shown an inverse association between consumption of omega-3 fatty acids from fish and/or fish oil supplements and breast cancer incidence (18).…”
The ratio of omega-3 to omega-6 fatty acids, especially the longchain eicosapentaenoic acid (EPA) þ docosahexaenoic acid (DHA) to arachidonic acid (AA) ratio, is inversely associated with breast cancer risk. We measured the association between cytologic atypia, a biomarker for short-term risk of breast cancer development, and omega-3 and omega-6 fatty acid intake and levels in blood and breast tissue. Blood and benign breast tissue, sampled by random periareolar fine-needle aspiration (RPFNA), was obtained from 70 women at elevated risk for breast cancer. Self-reported dietary intake was assessed by the NCI's Food Frequency Questionnaire. The fatty acid composition of five lipid compartments, red blood cell, plasma and breast phospholipids, and plasma and breast triaclyglycerides (TAG), was analyzed by gas chromatography as weight percent. Median daily intakes of EPAþDHA and total omega-3 fatty acids were 80 mg and 1.1 g, respectively. The median total omega-3:6 intake ratio was 1:10. Compared with women without atypia, those with cytologic atypia had lower total omega-3 fatty acids in red blood cell and plasma phospholipids and lower omega-3:6 ratios in plasma TAGs and breast TAGs (P < 0.05). The EPAþDHA:AA ratio in plasma TAGs was also lower among women with atypia. This is the first report of associations between tissue levels of omega-3 and omega-6 fatty acids and a reversible tissue biomarker of breast cancer risk. RPFNA cytomorphology could serve as a surrogate endpoint for breast cancer prevention trials of omega-3 fatty acid supplementation. Cancer Prev Res; 8(5); 359-64. Ó2015 AACR.
“…Most prominently, this association has been noted in cultures such as Greenland, Alaska and Japan, where a natural high dietary intake of fish oils is maintained. As a result, a number of publications have been able to demonstrate that an increased consumption of omega-3 fatty acids such as EPA and DHA lead to a reduction in colorectal [ 143 , 144 , 145 ] and breast [ 146 ] cancer risk respectively. Clearly, the main role of omega-3 in tumourigenesis lies in the reduction of cancer risk and inhibition of cancer cell growth [147].…”
Section: Influence Of Dietary Fats On Aa Cascadementioning
Lastly, the benefits of dietary omega-3 fatty acids and their mechanisms of action leading to reduced cancer risk and impeded cancer cell growth are mentioned. Finally, a proposal is put forward, suggesting a novel and integrated approach in viewing the molecular mechanisms and complex interactions responsible for the involvement of AA metabolites in carcinogenesis and the protective effects of omega-3 fatty acids in inflammation and tumour prevention.
“…29). The study design has been elsewhere described (29), and the investigation was executed in series within the Aichi Fatty Acid (AiFat) Research project to clarify associations between a large number of blood parameters and cancers in several sites (28,30,31). Briefly, all first-visit outpatients (n = 18,103), including all cancer cases (n = 3,972), were asked to fill out a questionnaire regarding their lifestyle and to provide 7-mL blood samples.…”
Section: Methodsmentioning
confidence: 99%
“…Our questionnaire covered the following personal information: height, weight, dietary habits, habitual exercise, drinking habit, smoking status, and thorough medical information such as family history of cancer and current and prevalent history of diseases. Dietary assessment was elsewhere described in detail (30,31). In brief, average daily intakes of various foods and nutrients were assessed using a semiquantitative food frequency questionnaire with 47 food items, which had an acceptable relative validity and reproducibility for their consumption (33)(34)(35).…”
Infection with Helicobacter pylori is linked to inflammation and is the main cause of peptic ulcer, gastritis, and gastric malignancies. To examine associations between gastric cancer risk and the erythrocyte composition of docosahexaenoic acid (DHA), a fatty acid with antiinflammatory and apoptosis-inducing effects, here we conducted a case-control study of 179 incident gastric cancer cases and 357 noncancer controls (matched by age, sex, and season of sample collection). Dietary information and blood samples were collected from all subjects, and erythrocyte fatty acid levels were measured using accelerated solvent extraction and gas-liquid chromatography. Gastric cancer risk did not seem to be directly associated with dietary intake of fish and n-3 highly unsaturated fatty acids (HUFAs), such as DHA, derived from fish. However, risk was inversely associated with erythrocyte compositions of n-3 HUFAs [the highest to the lowest tertile, odds ratio (OR), 0.39; 95% confidence interval (95% CI), 0.23-0.68; P trend < 0.005] and DHA (OR, 0.47; 95% CI, 0.28-0.79; P trend < 0.01). Particularly strong associations were noted for well-differentiated type lesions and n-3 HUFAs (OR, 0.10; 95% CI, 0.03-0.35; P trend = 0.0005) as well as DHA (OR, 0.20; 95% CI, 0.07-0.58; P trend < 0.01) values. In conclusion, the erythrocyte composition of DHA was found to be negatively linked to risk of gastric cancer, especially of well-differentiated adenocarcinoma. Further studies are needed to investigate mechanisms of action of DHA relevant to antitumor effects in the stomach. (Cancer Epidemiol Biomarkers Prev 2007;16(11):2406 -15)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.